European Parliament Members Urge Open Licensing For COVID-19 Products Financed Through EU Grants 27/03/2020 Grace Ren Some 33 Members of the European Parliament released an open letter Friday urging top leadership in the European Commission (EC) to prohibit exclusive licensing for COVID-19 products developed with European Union (EU) grants, and demanding transparency in the research and development pipeline to ensure affordability commitments are met. In a separate letter signed by 37 […] Continue reading -> Testing For Coronavirus – Can Latin America and Africa Build Upon The Asian Model? 25/03/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 In normal times, Diego Zapata, undersecretary in the City of Medellin’s Mobility Department, worries about how to advance better public transit systems, cycling and pedestrian networks – to get more people moving around the city. But recently, he and his boss Carlos Cadena began supporting the City’s Health Department in its scramble to reduce travel […] Continue reading -> Médecins Sans Frontières Announces Campaign For $5 COVID-19 Test On ‘GeneXpert’ TB Platform 24/03/2020 Grace Ren Médecins Sans Frontiéres (MSF) on Tuesday launched a campaign to push for a US $5 price tag on a new COVID-19 rapid diagnostic test that can be used on GeneXpert, a diagnostic instrument widely deployed around the world for diagnosing tuberculosis. The test for SARS-CoV-2, the virus that causes COVID-19, received US Food and Drug […] Continue reading -> New COVID-19 Rapid Diagnostic Approved On ‘GeneXpert’ TB Platform; Could Pave Way For More Testing In Low- & Middle-Income Countries 23/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay US Food & Drug Administration authorization of a rapid COVID-19 test on the GeneXpert platform, one of the most widely-used TB diagnostic tools in the world, could be the first crack in the doorway to wider testing capacity in low- and middle-income countries, leading TB advocates told Health Policy Watch. There are some 23,000 GeneXpert […] Continue reading -> Going ‘Virtual’ In Global Health – Practices Are Changing Fast – But At An Uneven Pace 12/03/2020 Elaine Ruth Fletcher As the COVID-19 crisis seeps into financial markets, corporate board rooms, and global health systems, there may be one silver lining in an otherwise dark cloud. The 21st century era of digital health, virtual meetings and teleworking is upon us. Countries as far-flung as the Republic of Korea, Israel and even some forward-looking US health […] Continue reading -> COVID-19 Begins To Impact Drug Supplies; Infections Accelerate in Iran, Across Europe & United States 04/03/2020 Elaine Ruth Fletcher As the COVID-19 continued its march across the planet, shortages of some key drug ingredients were beginning to be felt in some markets, and iconic events such as the World Bank’s annual spring meeting were to be moved to a virtual platform. In Geneva, parallel sessions and side events involving the ongoing annual meetings of […] Continue reading -> New Consortium Aims To Develop “Pan-TB” Treatment Regimen 29/02/2020 Grace Ren While health leaders battle a global outbreak of a dangerous new virus, a consortium of partners is entering the fight against one of humankind’s oldest infectious diseases, tuberculosis. A group of philanthropic, non-profit, and private sector organizations on Thursday launched a collaboration to accelerate development for a “pan-TB” treatment regimen to treat drug-sensitive and drug-resistant […] Continue reading -> WHO Head Praises China Response To Coronavirus Emergency; Criticizes “Unnecessary” Trade and Travel Restrictions 03/02/2020 Elaine Ruth Fletcher World Health Organization Director General Dr Tedros Adhanom Ghebreyesus called for “solidarity, solidarity and solidarity” amongst WHO member states to meet the new challenge of a novel coronavirus epidemic – at Monday’s opening of a week-long meeting of WHO’s Executive Board in Geneva. “The rule of the game is solidarity, solidarity, solidarity. But we see […] Continue reading -> What To Watch At The Executive Board: Emergencies, Universal Health Coverage & Eliminating Cervical Cancer 03/02/2020 Grace Ren and Catherine Saez This week’s Executive Board meeting features a heavy agenda of topics, including a review of progress in WHO’s flagship Universal Health Coverage (UHC) initiative; steps taken to confront the burgeoning coronavirus health emergency; and review of a first-ever WHO strategy to eliminate cervical cancer. Debates over the long-term challenges posed by drug resistant pathogens and […] Continue reading -> R&D Funding For Leading Infectious Diseases Reaches Record High; But Investments Plateau For Neglected Tropical Diseases 30/01/2020 Grace Ren and Elaine Ruth Fletcher Funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB and malaria, reached a record high of US $4 billion in 2018, with private sector investment driving much of the increase, according to the 2019 G-FINDER Report, which tracks such investments globally. However, investments in neglected tropical […] Continue reading -> Posts navigation Older postsNewer posts
Testing For Coronavirus – Can Latin America and Africa Build Upon The Asian Model? 25/03/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227 In normal times, Diego Zapata, undersecretary in the City of Medellin’s Mobility Department, worries about how to advance better public transit systems, cycling and pedestrian networks – to get more people moving around the city. But recently, he and his boss Carlos Cadena began supporting the City’s Health Department in its scramble to reduce travel […] Continue reading -> Médecins Sans Frontières Announces Campaign For $5 COVID-19 Test On ‘GeneXpert’ TB Platform 24/03/2020 Grace Ren Médecins Sans Frontiéres (MSF) on Tuesday launched a campaign to push for a US $5 price tag on a new COVID-19 rapid diagnostic test that can be used on GeneXpert, a diagnostic instrument widely deployed around the world for diagnosing tuberculosis. The test for SARS-CoV-2, the virus that causes COVID-19, received US Food and Drug […] Continue reading -> New COVID-19 Rapid Diagnostic Approved On ‘GeneXpert’ TB Platform; Could Pave Way For More Testing In Low- & Middle-Income Countries 23/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay US Food & Drug Administration authorization of a rapid COVID-19 test on the GeneXpert platform, one of the most widely-used TB diagnostic tools in the world, could be the first crack in the doorway to wider testing capacity in low- and middle-income countries, leading TB advocates told Health Policy Watch. There are some 23,000 GeneXpert […] Continue reading -> Going ‘Virtual’ In Global Health – Practices Are Changing Fast – But At An Uneven Pace 12/03/2020 Elaine Ruth Fletcher As the COVID-19 crisis seeps into financial markets, corporate board rooms, and global health systems, there may be one silver lining in an otherwise dark cloud. The 21st century era of digital health, virtual meetings and teleworking is upon us. Countries as far-flung as the Republic of Korea, Israel and even some forward-looking US health […] Continue reading -> COVID-19 Begins To Impact Drug Supplies; Infections Accelerate in Iran, Across Europe & United States 04/03/2020 Elaine Ruth Fletcher As the COVID-19 continued its march across the planet, shortages of some key drug ingredients were beginning to be felt in some markets, and iconic events such as the World Bank’s annual spring meeting were to be moved to a virtual platform. In Geneva, parallel sessions and side events involving the ongoing annual meetings of […] Continue reading -> New Consortium Aims To Develop “Pan-TB” Treatment Regimen 29/02/2020 Grace Ren While health leaders battle a global outbreak of a dangerous new virus, a consortium of partners is entering the fight against one of humankind’s oldest infectious diseases, tuberculosis. A group of philanthropic, non-profit, and private sector organizations on Thursday launched a collaboration to accelerate development for a “pan-TB” treatment regimen to treat drug-sensitive and drug-resistant […] Continue reading -> WHO Head Praises China Response To Coronavirus Emergency; Criticizes “Unnecessary” Trade and Travel Restrictions 03/02/2020 Elaine Ruth Fletcher World Health Organization Director General Dr Tedros Adhanom Ghebreyesus called for “solidarity, solidarity and solidarity” amongst WHO member states to meet the new challenge of a novel coronavirus epidemic – at Monday’s opening of a week-long meeting of WHO’s Executive Board in Geneva. “The rule of the game is solidarity, solidarity, solidarity. But we see […] Continue reading -> What To Watch At The Executive Board: Emergencies, Universal Health Coverage & Eliminating Cervical Cancer 03/02/2020 Grace Ren and Catherine Saez This week’s Executive Board meeting features a heavy agenda of topics, including a review of progress in WHO’s flagship Universal Health Coverage (UHC) initiative; steps taken to confront the burgeoning coronavirus health emergency; and review of a first-ever WHO strategy to eliminate cervical cancer. Debates over the long-term challenges posed by drug resistant pathogens and […] Continue reading -> R&D Funding For Leading Infectious Diseases Reaches Record High; But Investments Plateau For Neglected Tropical Diseases 30/01/2020 Grace Ren and Elaine Ruth Fletcher Funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB and malaria, reached a record high of US $4 billion in 2018, with private sector investment driving much of the increase, according to the 2019 G-FINDER Report, which tracks such investments globally. However, investments in neglected tropical […] Continue reading -> Posts navigation Older postsNewer posts
Médecins Sans Frontières Announces Campaign For $5 COVID-19 Test On ‘GeneXpert’ TB Platform 24/03/2020 Grace Ren Médecins Sans Frontiéres (MSF) on Tuesday launched a campaign to push for a US $5 price tag on a new COVID-19 rapid diagnostic test that can be used on GeneXpert, a diagnostic instrument widely deployed around the world for diagnosing tuberculosis. The test for SARS-CoV-2, the virus that causes COVID-19, received US Food and Drug […] Continue reading -> New COVID-19 Rapid Diagnostic Approved On ‘GeneXpert’ TB Platform; Could Pave Way For More Testing In Low- & Middle-Income Countries 23/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay US Food & Drug Administration authorization of a rapid COVID-19 test on the GeneXpert platform, one of the most widely-used TB diagnostic tools in the world, could be the first crack in the doorway to wider testing capacity in low- and middle-income countries, leading TB advocates told Health Policy Watch. There are some 23,000 GeneXpert […] Continue reading -> Going ‘Virtual’ In Global Health – Practices Are Changing Fast – But At An Uneven Pace 12/03/2020 Elaine Ruth Fletcher As the COVID-19 crisis seeps into financial markets, corporate board rooms, and global health systems, there may be one silver lining in an otherwise dark cloud. The 21st century era of digital health, virtual meetings and teleworking is upon us. Countries as far-flung as the Republic of Korea, Israel and even some forward-looking US health […] Continue reading -> COVID-19 Begins To Impact Drug Supplies; Infections Accelerate in Iran, Across Europe & United States 04/03/2020 Elaine Ruth Fletcher As the COVID-19 continued its march across the planet, shortages of some key drug ingredients were beginning to be felt in some markets, and iconic events such as the World Bank’s annual spring meeting were to be moved to a virtual platform. In Geneva, parallel sessions and side events involving the ongoing annual meetings of […] Continue reading -> New Consortium Aims To Develop “Pan-TB” Treatment Regimen 29/02/2020 Grace Ren While health leaders battle a global outbreak of a dangerous new virus, a consortium of partners is entering the fight against one of humankind’s oldest infectious diseases, tuberculosis. A group of philanthropic, non-profit, and private sector organizations on Thursday launched a collaboration to accelerate development for a “pan-TB” treatment regimen to treat drug-sensitive and drug-resistant […] Continue reading -> WHO Head Praises China Response To Coronavirus Emergency; Criticizes “Unnecessary” Trade and Travel Restrictions 03/02/2020 Elaine Ruth Fletcher World Health Organization Director General Dr Tedros Adhanom Ghebreyesus called for “solidarity, solidarity and solidarity” amongst WHO member states to meet the new challenge of a novel coronavirus epidemic – at Monday’s opening of a week-long meeting of WHO’s Executive Board in Geneva. “The rule of the game is solidarity, solidarity, solidarity. But we see […] Continue reading -> What To Watch At The Executive Board: Emergencies, Universal Health Coverage & Eliminating Cervical Cancer 03/02/2020 Grace Ren and Catherine Saez This week’s Executive Board meeting features a heavy agenda of topics, including a review of progress in WHO’s flagship Universal Health Coverage (UHC) initiative; steps taken to confront the burgeoning coronavirus health emergency; and review of a first-ever WHO strategy to eliminate cervical cancer. Debates over the long-term challenges posed by drug resistant pathogens and […] Continue reading -> R&D Funding For Leading Infectious Diseases Reaches Record High; But Investments Plateau For Neglected Tropical Diseases 30/01/2020 Grace Ren and Elaine Ruth Fletcher Funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB and malaria, reached a record high of US $4 billion in 2018, with private sector investment driving much of the increase, according to the 2019 G-FINDER Report, which tracks such investments globally. However, investments in neglected tropical […] Continue reading -> Posts navigation Older postsNewer posts
New COVID-19 Rapid Diagnostic Approved On ‘GeneXpert’ TB Platform; Could Pave Way For More Testing In Low- & Middle-Income Countries 23/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay US Food & Drug Administration authorization of a rapid COVID-19 test on the GeneXpert platform, one of the most widely-used TB diagnostic tools in the world, could be the first crack in the doorway to wider testing capacity in low- and middle-income countries, leading TB advocates told Health Policy Watch. There are some 23,000 GeneXpert […] Continue reading -> Going ‘Virtual’ In Global Health – Practices Are Changing Fast – But At An Uneven Pace 12/03/2020 Elaine Ruth Fletcher As the COVID-19 crisis seeps into financial markets, corporate board rooms, and global health systems, there may be one silver lining in an otherwise dark cloud. The 21st century era of digital health, virtual meetings and teleworking is upon us. Countries as far-flung as the Republic of Korea, Israel and even some forward-looking US health […] Continue reading -> COVID-19 Begins To Impact Drug Supplies; Infections Accelerate in Iran, Across Europe & United States 04/03/2020 Elaine Ruth Fletcher As the COVID-19 continued its march across the planet, shortages of some key drug ingredients were beginning to be felt in some markets, and iconic events such as the World Bank’s annual spring meeting were to be moved to a virtual platform. In Geneva, parallel sessions and side events involving the ongoing annual meetings of […] Continue reading -> New Consortium Aims To Develop “Pan-TB” Treatment Regimen 29/02/2020 Grace Ren While health leaders battle a global outbreak of a dangerous new virus, a consortium of partners is entering the fight against one of humankind’s oldest infectious diseases, tuberculosis. A group of philanthropic, non-profit, and private sector organizations on Thursday launched a collaboration to accelerate development for a “pan-TB” treatment regimen to treat drug-sensitive and drug-resistant […] Continue reading -> WHO Head Praises China Response To Coronavirus Emergency; Criticizes “Unnecessary” Trade and Travel Restrictions 03/02/2020 Elaine Ruth Fletcher World Health Organization Director General Dr Tedros Adhanom Ghebreyesus called for “solidarity, solidarity and solidarity” amongst WHO member states to meet the new challenge of a novel coronavirus epidemic – at Monday’s opening of a week-long meeting of WHO’s Executive Board in Geneva. “The rule of the game is solidarity, solidarity, solidarity. But we see […] Continue reading -> What To Watch At The Executive Board: Emergencies, Universal Health Coverage & Eliminating Cervical Cancer 03/02/2020 Grace Ren and Catherine Saez This week’s Executive Board meeting features a heavy agenda of topics, including a review of progress in WHO’s flagship Universal Health Coverage (UHC) initiative; steps taken to confront the burgeoning coronavirus health emergency; and review of a first-ever WHO strategy to eliminate cervical cancer. Debates over the long-term challenges posed by drug resistant pathogens and […] Continue reading -> R&D Funding For Leading Infectious Diseases Reaches Record High; But Investments Plateau For Neglected Tropical Diseases 30/01/2020 Grace Ren and Elaine Ruth Fletcher Funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB and malaria, reached a record high of US $4 billion in 2018, with private sector investment driving much of the increase, according to the 2019 G-FINDER Report, which tracks such investments globally. However, investments in neglected tropical […] Continue reading -> Posts navigation Older postsNewer posts
Going ‘Virtual’ In Global Health – Practices Are Changing Fast – But At An Uneven Pace 12/03/2020 Elaine Ruth Fletcher As the COVID-19 crisis seeps into financial markets, corporate board rooms, and global health systems, there may be one silver lining in an otherwise dark cloud. The 21st century era of digital health, virtual meetings and teleworking is upon us. Countries as far-flung as the Republic of Korea, Israel and even some forward-looking US health […] Continue reading -> COVID-19 Begins To Impact Drug Supplies; Infections Accelerate in Iran, Across Europe & United States 04/03/2020 Elaine Ruth Fletcher As the COVID-19 continued its march across the planet, shortages of some key drug ingredients were beginning to be felt in some markets, and iconic events such as the World Bank’s annual spring meeting were to be moved to a virtual platform. In Geneva, parallel sessions and side events involving the ongoing annual meetings of […] Continue reading -> New Consortium Aims To Develop “Pan-TB” Treatment Regimen 29/02/2020 Grace Ren While health leaders battle a global outbreak of a dangerous new virus, a consortium of partners is entering the fight against one of humankind’s oldest infectious diseases, tuberculosis. A group of philanthropic, non-profit, and private sector organizations on Thursday launched a collaboration to accelerate development for a “pan-TB” treatment regimen to treat drug-sensitive and drug-resistant […] Continue reading -> WHO Head Praises China Response To Coronavirus Emergency; Criticizes “Unnecessary” Trade and Travel Restrictions 03/02/2020 Elaine Ruth Fletcher World Health Organization Director General Dr Tedros Adhanom Ghebreyesus called for “solidarity, solidarity and solidarity” amongst WHO member states to meet the new challenge of a novel coronavirus epidemic – at Monday’s opening of a week-long meeting of WHO’s Executive Board in Geneva. “The rule of the game is solidarity, solidarity, solidarity. But we see […] Continue reading -> What To Watch At The Executive Board: Emergencies, Universal Health Coverage & Eliminating Cervical Cancer 03/02/2020 Grace Ren and Catherine Saez This week’s Executive Board meeting features a heavy agenda of topics, including a review of progress in WHO’s flagship Universal Health Coverage (UHC) initiative; steps taken to confront the burgeoning coronavirus health emergency; and review of a first-ever WHO strategy to eliminate cervical cancer. Debates over the long-term challenges posed by drug resistant pathogens and […] Continue reading -> R&D Funding For Leading Infectious Diseases Reaches Record High; But Investments Plateau For Neglected Tropical Diseases 30/01/2020 Grace Ren and Elaine Ruth Fletcher Funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB and malaria, reached a record high of US $4 billion in 2018, with private sector investment driving much of the increase, according to the 2019 G-FINDER Report, which tracks such investments globally. However, investments in neglected tropical […] Continue reading -> Posts navigation Older postsNewer posts
COVID-19 Begins To Impact Drug Supplies; Infections Accelerate in Iran, Across Europe & United States 04/03/2020 Elaine Ruth Fletcher As the COVID-19 continued its march across the planet, shortages of some key drug ingredients were beginning to be felt in some markets, and iconic events such as the World Bank’s annual spring meeting were to be moved to a virtual platform. In Geneva, parallel sessions and side events involving the ongoing annual meetings of […] Continue reading -> New Consortium Aims To Develop “Pan-TB” Treatment Regimen 29/02/2020 Grace Ren While health leaders battle a global outbreak of a dangerous new virus, a consortium of partners is entering the fight against one of humankind’s oldest infectious diseases, tuberculosis. A group of philanthropic, non-profit, and private sector organizations on Thursday launched a collaboration to accelerate development for a “pan-TB” treatment regimen to treat drug-sensitive and drug-resistant […] Continue reading -> WHO Head Praises China Response To Coronavirus Emergency; Criticizes “Unnecessary” Trade and Travel Restrictions 03/02/2020 Elaine Ruth Fletcher World Health Organization Director General Dr Tedros Adhanom Ghebreyesus called for “solidarity, solidarity and solidarity” amongst WHO member states to meet the new challenge of a novel coronavirus epidemic – at Monday’s opening of a week-long meeting of WHO’s Executive Board in Geneva. “The rule of the game is solidarity, solidarity, solidarity. But we see […] Continue reading -> What To Watch At The Executive Board: Emergencies, Universal Health Coverage & Eliminating Cervical Cancer 03/02/2020 Grace Ren and Catherine Saez This week’s Executive Board meeting features a heavy agenda of topics, including a review of progress in WHO’s flagship Universal Health Coverage (UHC) initiative; steps taken to confront the burgeoning coronavirus health emergency; and review of a first-ever WHO strategy to eliminate cervical cancer. Debates over the long-term challenges posed by drug resistant pathogens and […] Continue reading -> R&D Funding For Leading Infectious Diseases Reaches Record High; But Investments Plateau For Neglected Tropical Diseases 30/01/2020 Grace Ren and Elaine Ruth Fletcher Funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB and malaria, reached a record high of US $4 billion in 2018, with private sector investment driving much of the increase, according to the 2019 G-FINDER Report, which tracks such investments globally. However, investments in neglected tropical […] Continue reading -> Posts navigation Older postsNewer posts
New Consortium Aims To Develop “Pan-TB” Treatment Regimen 29/02/2020 Grace Ren While health leaders battle a global outbreak of a dangerous new virus, a consortium of partners is entering the fight against one of humankind’s oldest infectious diseases, tuberculosis. A group of philanthropic, non-profit, and private sector organizations on Thursday launched a collaboration to accelerate development for a “pan-TB” treatment regimen to treat drug-sensitive and drug-resistant […] Continue reading -> WHO Head Praises China Response To Coronavirus Emergency; Criticizes “Unnecessary” Trade and Travel Restrictions 03/02/2020 Elaine Ruth Fletcher World Health Organization Director General Dr Tedros Adhanom Ghebreyesus called for “solidarity, solidarity and solidarity” amongst WHO member states to meet the new challenge of a novel coronavirus epidemic – at Monday’s opening of a week-long meeting of WHO’s Executive Board in Geneva. “The rule of the game is solidarity, solidarity, solidarity. But we see […] Continue reading -> What To Watch At The Executive Board: Emergencies, Universal Health Coverage & Eliminating Cervical Cancer 03/02/2020 Grace Ren and Catherine Saez This week’s Executive Board meeting features a heavy agenda of topics, including a review of progress in WHO’s flagship Universal Health Coverage (UHC) initiative; steps taken to confront the burgeoning coronavirus health emergency; and review of a first-ever WHO strategy to eliminate cervical cancer. Debates over the long-term challenges posed by drug resistant pathogens and […] Continue reading -> R&D Funding For Leading Infectious Diseases Reaches Record High; But Investments Plateau For Neglected Tropical Diseases 30/01/2020 Grace Ren and Elaine Ruth Fletcher Funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB and malaria, reached a record high of US $4 billion in 2018, with private sector investment driving much of the increase, according to the 2019 G-FINDER Report, which tracks such investments globally. However, investments in neglected tropical […] Continue reading -> Posts navigation Older postsNewer posts
WHO Head Praises China Response To Coronavirus Emergency; Criticizes “Unnecessary” Trade and Travel Restrictions 03/02/2020 Elaine Ruth Fletcher World Health Organization Director General Dr Tedros Adhanom Ghebreyesus called for “solidarity, solidarity and solidarity” amongst WHO member states to meet the new challenge of a novel coronavirus epidemic – at Monday’s opening of a week-long meeting of WHO’s Executive Board in Geneva. “The rule of the game is solidarity, solidarity, solidarity. But we see […] Continue reading -> What To Watch At The Executive Board: Emergencies, Universal Health Coverage & Eliminating Cervical Cancer 03/02/2020 Grace Ren and Catherine Saez This week’s Executive Board meeting features a heavy agenda of topics, including a review of progress in WHO’s flagship Universal Health Coverage (UHC) initiative; steps taken to confront the burgeoning coronavirus health emergency; and review of a first-ever WHO strategy to eliminate cervical cancer. Debates over the long-term challenges posed by drug resistant pathogens and […] Continue reading -> R&D Funding For Leading Infectious Diseases Reaches Record High; But Investments Plateau For Neglected Tropical Diseases 30/01/2020 Grace Ren and Elaine Ruth Fletcher Funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB and malaria, reached a record high of US $4 billion in 2018, with private sector investment driving much of the increase, according to the 2019 G-FINDER Report, which tracks such investments globally. However, investments in neglected tropical […] Continue reading -> Posts navigation Older postsNewer posts
What To Watch At The Executive Board: Emergencies, Universal Health Coverage & Eliminating Cervical Cancer 03/02/2020 Grace Ren and Catherine Saez This week’s Executive Board meeting features a heavy agenda of topics, including a review of progress in WHO’s flagship Universal Health Coverage (UHC) initiative; steps taken to confront the burgeoning coronavirus health emergency; and review of a first-ever WHO strategy to eliminate cervical cancer. Debates over the long-term challenges posed by drug resistant pathogens and […] Continue reading -> R&D Funding For Leading Infectious Diseases Reaches Record High; But Investments Plateau For Neglected Tropical Diseases 30/01/2020 Grace Ren and Elaine Ruth Fletcher Funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB and malaria, reached a record high of US $4 billion in 2018, with private sector investment driving much of the increase, according to the 2019 G-FINDER Report, which tracks such investments globally. However, investments in neglected tropical […] Continue reading -> Posts navigation Older postsNewer posts
R&D Funding For Leading Infectious Diseases Reaches Record High; But Investments Plateau For Neglected Tropical Diseases 30/01/2020 Grace Ren and Elaine Ruth Fletcher Funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB and malaria, reached a record high of US $4 billion in 2018, with private sector investment driving much of the increase, according to the 2019 G-FINDER Report, which tracks such investments globally. However, investments in neglected tropical […] Continue reading -> Posts navigation Older postsNewer posts